Incyte (INCY) Cash from Operations (QoQ) (2010 - 2026)
Incyte (INCY) Cash from Operations (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Incyte | 23.33 Bn | 19.32 Bn | 1.17 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.02% |
| Dec 31, 2025 | -2.88% |
| Sep 30, 2025 | 1,150.28% |
| Jun 30, 2025 | -83.18% |
| Mar 31, 2025 | -30.21% |
| Dec 31, 2024 | 22.63% |
| Sep 30, 2024 | 154.01% |
| Jun 30, 2024 | -363.04% |
| Mar 31, 2024 | 48.12% |
| Dec 31, 2023 | -0.07% |
| Sep 30, 2023 | -51.77% |
| Jun 30, 2023 | 390.26% |
| Mar 31, 2023 | -137.23% |
| Dec 31, 2022 | -4.29% |
| Sep 30, 2022 | 70.18% |
| Jun 30, 2022 | -19.27% |
| Mar 31, 2022 | 87.03% |
| Dec 31, 2021 | -54.78% |
| Sep 30, 2021 | 47.50% |
| Jun 30, 2021 | -16.09% |